Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. - Wikidata - awgldk - TriplyDB

Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

http://www.wikidata.org/entity/Q41999917

about

Cathepsin S signals via PAR2 and generates a novel tethered ligand receptor agonist Increased dietary intake of vitamin A promotes aortic valve calcification in vivo Molecular Imaging of Angiogenesis and Vascular Remodeling in Cardiovascular Pathology Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune Cells Prognostic effect of high-flux hemodialysis in patients with chronic kidney disease Mechanisms of arterial calcifications and consequences for cardiovascular function Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease Molecular and cellular aspects of calcific aortic valve disease Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques.Sortilin mediates vascular calcification via its recruitment into extracellular vesicles Reduced sox9 function promotes heart valve calcification phenotypes in vivo Medial vascular calcification revisited: review and perspectives Molecular imaging of inflammation in atherosclerosis.Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis Calcific aortic valve stenosis: methods, models, and mechanisms Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice.The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling.Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.Nanoparticle targeting to diseased vasculature for imaging and therapy.Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation Defining the acute kidney injury and repair transcriptome Role of angiogenetic factors in cardiac valve homeostasis and disease.Elastogenesis at the onset of human cardiac valve development.A current understanding of vascular calcification in CKD.Potential drug targets for calcific aortic valve disease.Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease.Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform.Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly.Cathepsin S silencing induces apoptosis of human hepatocellular carcinoma cells Animal models of calcific aortic valve disease Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosis.Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease.Innate and Adaptive Immunity in Calcific Aortic Valve Disease Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease.

P2860

Q21132011-E611A287-B87F-46CC-938E-C172F2D9C96C Q24630155-4332DB06-092A-45BE-8D6F-50750A63FE23 Q26747500-98686055-FC83-47AD-9852-38F2CB122AF0 Q26764864-B9AEDC37-D797-4902-85C6-DDE6778BC4E6 Q26775524-D5EB7BB7-8854-4368-AA3D-0B41ED2A5C61 Q26821993-5667938D-2218-47A0-ADAE-1194668797A3 Q26825215-B624E066-EEC3-4EC4-AB62-2EC846A23B04 Q27024623-589AE436-F00B-40D1-8879-8C7587924F99 Q27026105-DC5FAACD-30C8-4694-9140-7446FC5771D6 Q27314193-6649D947-5057-48D1-A378-72663E112E30 Q28273951-89879DEE-657E-4792-BE12-F2D71E30D11C Q28506607-15126E06-C3E0-4EEF-8DF8-23F23876AAAF Q30409314-A4558932-DAB1-4590-BDAB-8073E43831FD Q30446268-92430A50-CD23-4651-A5EA-125C4B9BB238 Q30474772-2CC54594-D909-41D8-9E82-B042AEECEC6B Q30502726-A5F08AC8-5953-4033-A502-DC8EDDC9691C Q30503246-D84CF2FD-C5B6-468B-9DE7-09D8AA99B24F Q33537691-E3A725CF-2D08-46A6-BFB3-95853E15391A Q33567788-3EF03D79-5BC9-47DC-B856-E6B38DFF3B79 Q33782750-5634D2A2-3A32-4936-9D94-418F4DF50A4B Q33819169-C0F27888-C635-41A8-A2CF-E013D1883E1A Q33831738-9ECE824B-2DB7-4F91-8CC8-7C28715B45F1 Q34065287-BC51F3AA-64D2-48A9-B3F5-9A47D39D1083 Q34180380-6C897D20-3CB1-4A4F-8214-6C5769BC9F55 Q34210751-F519B91E-9EEE-42DA-A22A-ABA0C7A5929F Q34342434-11908B92-5124-4542-BBC1-0FE1B188291F Q34355897-007B8C31-BDE4-41C6-B6A7-4691AFE372AB Q34399089-65C38071-CA27-4B82-BAE5-4DDCB9CE1B87 Q34623238-A59F3B15-BC57-4A71-BCBA-01B738695E0A Q34755816-D4A8B013-EA45-42A1-B782-0EE231CBDBE1 Q34772618-0D3EBCF2-9C0B-450F-A913-628A305E8F29 Q35116249-FD938661-F5C1-48A2-9E42-7E5C58E6B29E Q35137800-989C1AD7-9562-46DA-B539-A546E2B8ED3E Q35147157-5DD9D827-1D90-4DF0-9918-1E8E2885C6DE Q35190282-3ECC6834-0B27-4BDA-B0CD-B940676787A8 Q35268563-33048C75-2241-47B7-873C-20650E88CC50 Q35586730-F4510F43-BB65-41A2-A64F-B04CE30CD0AD Q35612638-8FAE0F1E-1213-439E-9D92-025348504DDD Q35679982-3D296EF1-5734-4A8A-A02E-81A243620796 Q35773020-B825AA2E-3948-4643-A667-9B27974DBC93

P2860

Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

http://www.wikidata.org/entity/Q41999917

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Arterial and aortic valve calc ...... ency in chronic renal disease.

@en

type

label

Arterial and aortic valve calc ...... ency in chronic renal disease.

@en

prefLabel

Arterial and aortic valve calc ...... ency in chronic renal disease.

@en

P1433

Q41999917-F3FB945F-33C3-4292-A641-CF5B20C8C474

P1476

Q41999917-D618E018-1688-4241-8112-126F0F1BE084

P2093

Q41999917-1E2B63FE-C528-4096-AFC9-170210D47E44

Q41999917-6F25A101-9775-4B83-B688-F2C1D8DEFA57

Q41999917-762C5E17-E5FB-4CD7-BCF9-7483ECC0470B

Q41999917-8C47D216-8D1D-40D0-976B-778C17A1C574

Q41999917-8E626696-9A4C-496C-AC22-15C0A4B2D82D

Q41999917-97F1F6AC-69AF-4FE8-8ADA-118028AEE566

Q41999917-C4385825-AECC-438B-8F0A-DD7F89635F2E

Q41999917-DAA4FBA7-5264-40CB-8C5B-0C615E0E441D

P2860

Q41999917-04342D6D-025F-4D67-8F97-05469174A9CD

Q41999917-13F26307-6274-4067-99B7-9ACE5CCFA3BD

Q41999917-168E04A3-267D-499B-9E68-F307D2FD4551

Q41999917-18F32F54-B2A8-43D7-AA95-2D80AEAD4618

Q41999917-1A863B89-363C-45F1-8178-5522F47C48C9

Q41999917-1D7B6F24-A4A9-4C70-BB71-98F583F9835E

Q41999917-49E8D33A-F7D3-4203-9F66-C0C6995D20A0

Q41999917-4B05D292-04B4-4BAC-BB6A-9FF7F327A682

Q41999917-5A29A033-0E7A-4C43-ABC7-08953FAD2B82

Q41999917-60E2B8D3-BE9C-406D-B93E-979EF702CEDB

P304

Q41999917-FB00EC32-BF45-4F4F-BC11-7F7F5A914379

P31

Q41999917-A2A246F5-C5D7-4570-A1A3-E6D247E4CFFB

P356

Q41999917-993E1CF5-4FFD-4DD6-9182-5C9570875261

P407

Q41999917-A406E739-47CD-47F4-9738-C2E09BD9A940

P433

Q41999917-01EC54D3-9033-4ECB-9358-045BD6CB8122

P478

Q41999917-05F9E7CB-9BD5-46E5-85AF-5C3F981FC364

P50

Q41999917-3BFD7726-4752-4B14-BE8C-A6CD47712843

Q41999917-6344223A-AE88-43C0-B77C-1D7B3C51048F

Q41999917-A3BCFB33-0FE7-4531-B948-38001457E7BE

P577

Q41999917-462CCE28-10DC-4971-A8F5-4D98E99BD9A9

P698

Q41999917-F15F39F9-BD8B-4343-A15D-98275EF25FE6

P932

Q41999917-7EE70A0F-C37B-4A33-BE2E-BF92CE3F46B4

P356

CIRCULATIONAHA.108.827972

P1433

P1476

Arterial and aortic valve calc ...... iency in chronic renal disease

@en

P2093

Daiju Fukuda

http://www.w3.org/2001/XMLSchema#string

Elena Aikawa

http://www.w3.org/2001/XMLSchema#string

Gabriel Rusanescu

http://www.w3.org/2001/XMLSchema#string

Guo-Ping Shi

http://www.w3.org/2001/XMLSchema#string

Jose-Luiz Figueiredo

http://www.w3.org/2001/XMLSchema#string

Masanori Aikawa

http://www.w3.org/2001/XMLSchema#string

Peter Libby

http://www.w3.org/2001/XMLSchema#string

Yoshiko Iwamoto

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo near-infrared fluorescence imaging of osteoblastic activity

The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis

Vascular calcification: pathobiology of a multifaceted disease

Elastic fibres.

Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts, and smooth muscle cells.

Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice

A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps.

Special characteristics of atherosclerosis in chronic renal failure.

Elastin as a matrikine.

Vascular calcification: mechanisms and clinical ramifications.

P304

1785-1794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.108.827972

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Rainer H Kohler

P577

2009-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19307473

http://www.w3.org/2001/XMLSchema#string

P932

2717745

http://www.w3.org/2001/XMLSchema#string